<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02690467</url>
  </required_header>
  <id_info>
    <org_study_id>AGO 02</org_study_id>
    <nct_id>NCT02690467</nct_id>
  </id_info>
  <brief_title>Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.</brief_title>
  <acronym>AGO 02</acronym>
  <official_title>Efficacy, Safety and Acceptability of the New Pen Needle 33G x 4 mm: a Cross-over Randomised Non Inferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Outcomes Research and Clinical Epidemiology, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Artsana S.p.a.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Center for Outcomes Research and Clinical Epidemiology, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the non-inferiority of a new Pic Insupen 34Gx3,5mm
      needle vs. a 32Gx4mm needle in terms of metabolic control, safety and acceptability in
      patients with diabetes treated with insulin.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 6, 2016</start_date>
  <completion_date type="Anticipated">July 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 23, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fructosamine levels</measure>
    <time_frame>3 weeks</time_frame>
    <description>Change from baseline in fructosamine levels after 3 weeks of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic variability expressed as the standard deviation of fasting blood and postprandial glucose levels</measure>
    <time_frame>3 weeks</time_frame>
    <description>Change from baseline in glycemic variability after 3 weeks of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily insulin dose</measure>
    <time_frame>3 weeks</time_frame>
    <description>Change from baseline in daily insulin dose after 3 weeks of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>3 weeks</time_frame>
    <description>Change from baseline in body weight after 3 weeks of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pain measured by visual analogue scale after 3 weeks of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction measured by a questionnaire</measure>
    <time_frame>3 weeks</time_frame>
    <description>Patient satisfaction measured by a questionnaire after 3 weeks of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with hypoglycaemia</measure>
    <time_frame>3 weeks</time_frame>
    <description>Number of patients with hypoglycaemia during 3 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hypoglycaemia episodes</measure>
    <time_frame>3 weeks</time_frame>
    <description>Total number of phypoglycaemia episodes during 3 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of insulin leakage at injection site</measure>
    <time_frame>3 weeks</time_frame>
    <description>Number of episodes of insulin leakage at injection site during 3 weeks of treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Insupen G34x3,5mm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Needle for insulin pen 3,5 mm long and with a diameter of 34 gauge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insupen G32x4mm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Needle for insulin pen 4 mm long and with a diameter of 32 gauge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insupen G34x3,5mm</intervention_name>
    <arm_group_label>Insupen G34x3,5mm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insupen G32x4mm</intervention_name>
    <arm_group_label>Insupen G32x4mm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with type 1 or type 2 diabetes

          -  Age &gt;= 18 years

          -  Multiple daily injections of insulin for at least 6 months

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy or or breast feeding

          -  Inability to fill in the questionnaire

          -  Combined therapy for diabetes (oral drugs associated with insulin injections)

          -  Any medical condition that could interfere with the study according to the
             investigator's opinion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Nicolucci, MD</last_name>
    <phone>+39 085 9047114</phone>
    <email>nicolucci@coresearch.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>U.O. Malattie Metaboliche e Diabetologia - Ospedale Treviglio</name>
      <address>
        <city>Treviglio</city>
        <state>BG</state>
        <zip>24047</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Bossi, MD</last_name>
      <phone>+39 0363 424261</phone>
      <email>antonio_bossi@ospedale.treviglio.bg.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Struttura Semplice Dipartimentale di Diabetologia e Malattie Metaboliche - Az. Osp. S. Anna - PO Cant√π</name>
      <address>
        <city>Mariano Comense</city>
        <state>CO</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Sciangula, MD</last_name>
      <phone>+39 031 755355</phone>
      <email>luigi.sciangula@hsacomo.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Struttura Semplice Dipartimentale Diabetologia, Endocrinologia e Nutrizione Clinica - Az. Osp. Desio e Vimercate</name>
      <address>
        <city>Desio</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Marelli, MD</last_name>
      <phone>+39 0362383013</phone>
      <email>giuseppe.marelli@aovimercate.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Struttura Complessa Dietologia - Diabetologia Malattie Metaboliche - Ospedale Pertini</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00157</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Leotta, MD</last_name>
      <phone>+39 06 41433402</phone>
      <email>s.leotta@tiscali.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2016</study_first_submitted>
  <study_first_submitted_qc>February 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2016</study_first_posted>
  <last_update_submitted>July 24, 2017</last_update_submitted>
  <last_update_submitted_qc>July 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Insulin therapy</keyword>
  <keyword>Needle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

